European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

MBP Medical Biomaterial Products GmbH, Neustadt-Glewe, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

MBP Medical Biomaterial Products GmbH

Register

Ut
District Court of Schwerin HRB 4299

Address

Lederstr. 7, 19306 Neustadt-Glewe, Germany

Corporate purpose

The production and distribution of biopolymers and polymers, the production and distribution of collagens and the manufacture and distribution of medical, pharmaceutical and hygienic products.

Financials

Earnings Revenue

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

JOBS AT NORTH DATA

  • Modern Java Developer

Publications

14 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
1 Aug 2023
Wordmark: “Donorcoll“
1 Aug 2023
Wordmark: “Rematrix“
9 Jan 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
4 May 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
1 Oct 2021 in Fk
Public funding (€187,035): KollaGuard - a novel 'external stent' for better results in vascular surgery, subproject: Development of an external stent based on pure collagen scaffolds for scar-free …
4 Sept 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
15 Jan 2020
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
21 Nov 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
18 Jul 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
5 Apr 2017
Wordmark: “Xenoderm“
13 Jan 2017 via botiss medical AG
Shareholder: botiss medical AG
27 Oct 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
8 Sept 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
1 May 2015 in Fk
Public funding (€513,385): Micro- and nanoparticles from marine organisms (maresomes®) in collagen wound dressings to prevent colonization of multi-resistant pathogens (Nanomar) - Sub-projects: Wound …
4 Mar 2015
Original document: “Liste der Gesellschafter“
17 Dec 2014
Patent: GEL Layer
16 Dec 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
5 Aug 2014
Wordmark: “Donorcoll“
5 Aug 2014
Wordmark: “Rematrix“
28 Nov 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
16 Sept 2013
Managing Director: Dirk Pfützner · No longer Managing Director (1)
22 May 2013
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
1 Apr 2013 in Fk
Public funding (€174,090): ERA NET EuroTransBio-7: Scaffolds loaded with autologous stem cells for the regeneration of soft tissues, subproject Medical Biomaterial Products GmbH
29 May 2012
Capital: €51,400 · Share­holder agreement
20 Apr 2012
Original document: “Gesellschaftsvertrag / Satzung / Statut“
2 Jan 2012
Control: Composita GmbH
2 Jan 2012
Share­holder agreement
6 Dec 2011
Original document: “Unternehmensvertrag / Umwandlungsvertrag / sonstiger Vertrag“
21 Jul 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
1 Apr 2011
Managing Director (1) · No longer Managing Director (2) · Address
1 Apr 2011
Share­holder agreement
21 Mar 2011
Managing Director (1) · No longer Managing Director (1) · Address
16 Mar 2011
Wordmark: “Hemocol“
9 Nov 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
2 Mar 2010
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
23 Jun 2006
Reg­is­tra­tion · Managing Director (2) · Capital: 50,000 DEM · Seat: Neustadt-Glewe, Germany · Legal form: GmbH · Name: MBP Medical Biomaterial Products GmbH · Corporate Purpose

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "MBP Medical Biomaterial Products GmbH, Neustadt-Glewe, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close